Changes in the epidemiological trends of primary liver cancer in the Asia–Pacific region
Pojsakorn Danpanichkul(Texas Tech University), Apichat Kaewdech(Prince of Songkla University), Teerha Piratvisuth(Prince of Songkla University), Suthat Liangpunsakul(Indiana University School of Medicine), Markos Kalligeros(Beth Israel Deaconess Medical Center), Natchaya Polpichai(Weiss Memorial Hospital), Primrose Tothanarungroj(Chiang Mai University), Supapitch Sirimangklanurak(Chiang Mai University), Kanokphong Suparan(Chiang Mai University), Chuthathip Kaeosri(Chiang Mai University), Mindie H. Nguyen(Stanford Medicine), Banthoon Sukphutanan(Chiang Mai University), Karn Wijarnpreecha(University of Arizona), Pimsiri Sripongpun(Prince of Songkla University), Yanfang Pang(Affiliated Hospital of Youjiang Medical University for Nationalities), Naichaya Chamroonkul(Prince of Songkla University)
Cited by 35
Related Papers
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
|The Journal of Clinical Endocrinology & Metabolism|2022|306
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
|Clinical Gastroenterology and Hepatology|2023|126
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
|Journal of Hepatology|2022|121
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)
|Clinical Gastroenterology and Hepatology|2020|103